Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis

Cell Death and Differentiation

Volumn 6, Issue 1, 1999, Pages 13-21

  Ohsako, Satomi ^a   Elkon, Keith B ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Apoptosis; Autoimmunity; Diabetes mellitus; Multiple sclerosis; Systemic lupus erythematosus; Thyroiditis

Indexed keywords

APOPTOSIS; AUTOIMMUNE DISEASE; CELL DEATH; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; EFFECTOR CELL; HASHIMOTO DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; THYROID CELL; THYROIDITIS;

EID: 0032942973     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400459     Document Type: Review

References (75)

1. Smith CA, Farrah T and Goodwin RG (1994) The TNF receptor superfamily of cellularand viral proteins: activation, costimulation, and death. Cell 76: 959-962
2. Fraser A and Evan G (1996) A license to kill. Cell 85: 781-784
3. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687
4. Baldwin Jr AS (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 14: 649-683
5. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH and Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351
6. Sarin A, Conan-Cibotti M and Henkart PA (1995) Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155: 3716-3718
7. Orlinick JR, Vaishnaw AK and Elkon KB (1999) Structure and function of Fas/Fas ligand. Int. Rev. Immunol., In press
8. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
9. Griffith TS and Ferguson TA (1997) The role of FasL-induced apoptosis in immune privilege [published erratum appears in Immunol Today 1997 Jul; 18(7):361]. [Review] [46 refs]. Immunology. Today 18: 240-244
10. Kishimoto H, Surh CD and Sprent J (1998) A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187: 1427-1438
11. Van Parijs Land Abbas AK (1998) Homeostasis and self tolerance in the immune system: turning lymphocytes oft. Science 280: 243-248
12. Scott DW, Grdina T and Shi Y (1996) T cells commit suicide, but B cells are murdered! J. Immunol. 156: 2352-2356
13. Ashany D, Song X, Lacy E, Nikolik-Zugic J, Friedman SM and Elkon KB (1995) Lymphocytes delete activated macrophages through the Fas/APO-1 pathway. Proc. Natl. Acad. Sci. USA 92: 11225-11229
14. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, Zinkernagel RM and Hengartner H (1995) The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. European Journal of Immunology 25: 3256-3262
15. + T cell immunity to murine rotavirus in the absence of perforin, Fas, and gamma interferon. J. Virol. 71: 479-486
16. Heusel JW, Wesselschmidt R, Shresta S, Russell JH and Ley TJ (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987
17. Elkon KB (1998) Autoantibodies in SLE. In: Dieppe PA, Klippel JH, eds. Rheumatology. 2nd ed. Mosby Publishing: London. 1-10
18. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T and Datta SK (1995) Structure and specificity of T cell receptors expressed by poter tially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95: 531-541
19. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A and de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349
20. Fischer GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ and Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliferative syndrome. Cell 81: 935-946
21. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL and Elkon KB (1996) The Canale Smith syndrome: an inherited autoimmune disorder associated with defective lymphocyte apoptosis and mutations in the Fas gene. N. Engl. J. Med. 335: 1643-1649
22. Wu J, Wilson J, He J, Xiang L, Schur PH and Mountz JD (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98: 1107-1113
23. Strasser A, Whittingham S, Vaux DL, Beth ML, Adams JM, Cory S and Harris, AW (1991) Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Nat. Acad. Sci. USA 88: 8661-8665
24. Kozono Y, Kotzin BL and Holers VM (1996) Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J. Immunol. 156: 4498-4503
25. Hirose S, Van K, Abe M, Jiang Y, Hamano Y, Tsuru H and Shirai T (1997) Precursor B cells for autoantibody production in genomically Fas intact autoimmune disease are not subject to Fas-mediated imrrune elimination. Proc. Natl. Acad. Sci. USA 94: 9291-9295
26. Rosen A and Casciola-Rosen L (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6: 6-12
27. Mevorach D, Zhou J-L, Song X and Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp. Med. 188: 387-392
28. Vaishnaw AK, McNally JD and Elkon KB (1997) Apoptosis in the rheumatic diseases. Arthritis and Rheumatism 40: 1917-1927
29. Leist M, Single B, Castoldi AF, Kuhnle S and Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185: 1481-1486
30. Kikutani H and Makino S (1992) The murine autoimmune diabetes model; NOD and related strains. Advances in Immunology 51: 285-322
31. Andre I, Gonzalez A, Katz J, Wang B, Benoist C and Mathis D (1996) Checkpoints in the progression of autoimmune disease: Lessons from diabetic models. Proc. Natl. Acad. Sci. USA 6: 2260-2263
32. Tisch R and McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297
33. Delovitch TL and Singh B (1997) The non-obese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7: 727-738
34. + T cell-mediated cytotoxicity. J. Immunol. 152: 1127-1133
35. Kurrer MO, Pakala SV, Hanson HL and Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94: 213-218
36. Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM and Hengartner H (1996) Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183: 2143-2152
37. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RS and McDevitt HO (1994) Effect of tumor necrosis alpha on insulin-dependent diabetes mellitus in NOD mic. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180: 995-1004
38. Jacob CO, Also S, Michie SA, McDevitt HO and Acha-Orbea H (1990) Prevention of diabetes in non-obese diabetic mice by tumor necrosis factor (TNF) similarities between TNF-alpha and interleukm-1. Proc. Natl. Acad. Sci. USA 87: 968-972
39. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway Jr CA and Flavell RA (1996) Local expression of transgene encoded TNF-alpha in islets prevents autoimmune diabetes in non-obese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J. Exp. Med. 184: 1963-1974
40. Sarvertnick N (1996) Mechanisms of cytokine-mediated localized immunoprotection. J. Exp. Med. 184: 1597-1600
41. Cope AP, Liblau RS, Yang X-D, Congia M, Laudanna L, Schreiber RD, Probert L, Kollias G and McDevitt HO (1997) Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185: 1573-1584
42. Sallusto F and Lanzavecchia A (1994) Efficient preparation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118
43. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K. Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N and Matsuzawa Y (1997) Requirement of Fas for the development of autoimmune diabetes in non-obese diabetic mice. J. Exp. Med. 186: 613-618
44. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A and Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
45. Lau HT, Yu M, Fontana A and Stoeckert Jr CJ (1996) Prevention of islet allograft reception with engineered myoblasts expressing FasL in mice. Science 273: 109-112
46. Kang S-M, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG and Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3: 738-743
47. Chervonsky AV, Wang Y, Wong SF, Visintin I, Flavell RA, Janeway CA and Matis LA (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24
48. Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB and Humphreys-Beher MG (1997) Elevated levels of cystein protease activity in saliva and salivary glands of the non-obese diabetic (NOD) mouse model for Sjogren syndrome. Proc. Natl. Acad. Sci. USA 94: 5767-5771
49. Kong LO, Robinson CP, Peck AB, Vela-Roch N, Sakata A, Dang H. Talal N and Humphreys-Beher MG (1998) Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin. Exp. Rheumatol. in press
50. Elkon KB (1998) Fas (APO-1/CD95)-assisted suicide in NOD exocrine glands. Clin. Exp. Rheumatol., in press
51. Williams KC, Ulvestad E and Mickey WF (1994) Immunology of multiple sclerosis. Clin. Neurosci. 2: 229-245
52. Raine CS (1997) The Norton lecture: A review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77: 135-152
53. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS and Antel JP (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184: 2361-2370
54. Bonetti B and Raine CS (1997) Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42: 74-84
55. Dowling P, Shang G, Raval S, Menonna J, Cook S and Husar W (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184: 1513-1518
56. Olsson T (1995) Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144: 245-268
57. Frei K, Eugster H-P, Bopst M, Constantinescu CS, Lavi E and Fontana A (1997) Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 2177-2182
58. Suen WE, Bergman CM, Hjelmstrom P and Ruddle NH (1997) A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186: 1233-1240
59. Liu JL, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L and Bernard CA (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Medicine 4: 78-83
60. Sabelko KA, Kelly AK, Nahm MH, Cross AH and Russell JH (1997) Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159: 3096-3099
61. Waldner H, Sobel RA. Howard E and Kuchroo VK (1997) Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159: 3100-3103
62. Huitinga I, van Rooijen N, de Groot CJA, Uitdenhaag BMJ and Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172: 1025-1033
63. Nguyen KB, McCombe PA and Pender MP (1994). Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Autoimmun. 7: 145-152
64. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, Ito K and Nagataki S (1996) Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137: 3163-3169
65. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Tahara K, Ishikawa N, Ito K and Nagataki S (1997) Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin. Exp. Immunol. 110: 434-439
66. Arscott PL, Knapp J. Rymaszewski M, Bartron JL, Bretz JD, Thompson NW and Baker Jr JR (1997) Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 138: 5019-5027
67. Kotani T, Aratake Y, Hira K, Fukazawa Y, Sato H and Ontaki S (1995) Apoptosis in thyroid-tissue from patients with Hashimoto's thyroiditis. Autoimmunity 20: 231-235
68. Mirakian R (1997) Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J. Pathol. 182: 138-144
69. Giordano C, Stassi G, de Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R and Galluzzo A (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960-963
70. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, Meinders AE and Maini RN (1996) Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor χ monoclonal antibody treatments in patients with rheumatoid arthritis. Arthritis and Rheumatism 39: 1077-1081
71. Rodriguez I, Matsuura K, Ody C, Nagata S and Vassalli P (1996) Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184: 2067-2072
72. Pender MP, Nguyen KB, McCombe PA and Kerr JFR (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104: 81-87
73. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H and Lassmann H (1993) Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143: 446-452
74. Clark RB, Grunnet ML and Lingenheld EG (1997) The generation of encephalitogenic T cell lines from EAE-resistant strains of mice. Int. Immunol. 9: 1415-1422
75. Kouskoff V, Korganow A-S, Duchatelle V, Degott C, Benoist C and Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811-822